# Botulinum Toxin in Peripheral Neuropathic Pain

> **NCT01251211** · PHASE4 · COMPLETED · sponsor: **Hospital Ambroise Paré Paris** · enrollment: 66 (actual)

## Conditions studied

- Postherpetic Neuralgia
- Diabetic Polyneuropathies
- Other Polyneuropathies

## Interventions

- **DRUG:** botulinum toxin type A

## Key facts

- **NCT ID:** NCT01251211
- **Lead sponsor:** Hospital Ambroise Paré Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2016-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01251211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01251211, "Botulinum Toxin in Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01251211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*